Evidence map›Paper›PMID 15039322›Full record

ArticleInfection and immunity2004

The nature of extracellular iron influences iron acquisition by Mycobacterium tuberculosis residing within human macrophages.

Oyebode Olakanmi, Larry S Schlesinger, Ambar Ahmed, Bradley E Britigan

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Frontiers in immunology · 2022
    Article
  5. Review
  6. Article
  7. Dual Inhibition ofACS infectious diseases · 2019
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Frontiers in cellular and infection microbiology · 2017
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Iron in intracellular infection: to provide or to deprive?Frontiers in cellular and infection microbiology · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Oyebode OlakanmiDepartment of Internal Medicine and Research Service, VA Medical Center-Iowa City and Department of Internal Medicine, Roy G. and Lucille A. Carver College of Medicine, The University of Iowa, Iowa City, 52242, USA.
Larry S Schlesinger
Ambar Ahmed
Bradley E Britigan
Iowa City VA Medical Center · USThe Ohio State University · US

Funding

MACROPHAGE COMPLEMENT RECEPTORS IN TUBERCULOSISR01AI033004 · NIAID · UNIVERSITY OF IOWA · PI SCHLESINGER, LARRY S. · 1998 to 2002
$693k
GALLIUM THERAPY FOR MYCOBACTERIAL INFECTIONSR03AI043870 · NIAID · UNIVERSITY OF IOWA · PI SCHLESINGER, LARRY S. · 1998 to 1999
–
MACROPHAGE COMPLEMENT RECEPTORS IN TUBERCULOSISR29AI033004 · NIAID · UNIVERSITY OF IOWA · PI SCHLESINGER, LARRY S. · 1992 to 1996
–
NIAID NIH HHS AI33004NIAID NIH HHS AI43870
6 · The paper itself

Abstract

We have reported that Mycobacterium tuberculosis residing within the phagosomes of human monocyte-derived macrophages (MDM) can acquire Fe from extracellular transferrin (TF) and sources within the MDM. In the lung, Fe is also bound to lactoferrin (LF) and low-molecular-weight chelates. We therefore investigated the ability of intraphagosomal M. tuberculosis to acquire Fe from these sources. M. tuberculosis acquired 30-fold and 3-fold more Fe from LF and citrate, respectively, compared to TF, in spite of similar MDM-associated Fe. M. tuberculosis infection decreased MDM-associated Fe relative to uninfected MDM as follows: TF (38.7%), citrate (21.1%), and LF (15.3%). M. tuberculosis Fe acquisition from extracellular chelates (exogenous source) and from endogenous MDM Fe initially acquired from the three chelates (endogenous source) was compared. M. tuberculosis Fe acquisition was similar from exogenous and endogenous sources supplied as Fe-TF. In contrast, there was much greater intracellular M. tuberculosis Fe uptake from LF and citrate from the exogenous than endogenous source. Gamma interferon (IFN-gamma) reduced MDM Fe uptake from each chelate by approximately 50% and augmented the M. tuberculosis-induced decrease in MDM Fe uptake from exogenous TF, but not from LF or citrate. IFN-gamma minimally decreased intracellular M. tuberculosis Fe acquisition from exogenous Fe-TF but significantly increased Fe uptake from LF and citrate. Intraphagosomal M. tuberculosis Fe acquisition from both exogenous and endogenous MDM sources, and the effect of IFN-gamma on this process, is influenced by the nature of the extracellular Fe chelate. M. tuberculosis has developed efficient mechanisms of acquiring Fe from a variety of Fe chelates that it likely encounters within the human lung.

Indexed as

Cells, CulturedCitratesHumansInterferon-gammaIronLactoferrinMacrophagesMycobacterium tuberculosisPhagocytosisPhagosomesTuberculosisCitratesInterferon-gammaIronLactoferrin

Identifiers

PMID15039322
PMCPMC375202
OpenAlexW2145413901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.